Home / Import refusals / 112-1719361-9/1/1

FDA Import Refusal 112-1719361-9/1/1 — Sato Pharmaceutical Co., Ltd.

Sato Pharmaceutical Co., Ltd. — FEI 3004001417

The FDA refused shipment 112-1719361-9/1/1 from Sato Pharmaceutical Co., Ltd. (Taiwan) on December 12, 2011. The refused product falls under Drugs and Biologics — NAPHAZOLINE HCL (ADRENERGIC). Cited charges: 118,472,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 12, 2011
Country
Taiwan
Product Category
Drugs and Biologics
Product Code
60CDQ46 NAPHAZOLINE HCL (ADRENERGIC)
Charges
118,472,75

Other import refusals

  • 799-9603810-5/11/1 (Fri Mar 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-5600815-6/1/1 (Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 224-4713484-6/1/1 (Wed Aug 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 224-2480967-5/9/1 (Wed Dec 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)
  • 224-2480967-5/1/1 (Wed Dec 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)

FDA data resources